Nordic Precision Medicine Forum 2023 - 3 Conferences, 1 Venue

Nordic Precision Medicine returned to Stockholm after a hiatus due to COVID-19.

Just prior to the pandemic Sweden launched its first ever national Life Science Strategy in eight priority areas covering the strengthening of academic research, facilitating collaboration between academia and industry, attracting more industry initiated clinical trials, and the continuous skills development needed for precision medicine and highly advanced production of pharmaceuticals and medtech devices. Across the Nordic countries precision medicine and technology developments continue at pace, truly putting them in a favourable position when it comes to taking on the opportunities and challenges of implementing precision medicine, with its promise to really transform future healthcare as well as the entire life science sector.

Since 2016 we have convened the regions leading scientists, healthcare practitioners, and industry pioneers at our annual meeting. In 2022 there was a whole lot more interaction as we finally got back to in-person events.

We enjoyed seeing you in Stockholm and look forward to meeting up again in 2023!

Agenda (PDF)

Open the agenda for Nordic PMF as a PDF in a separate tab.

Nordic 2022 Speakers

Mattias Rantalainen, Associate Professor, PhD

Mattias Rantalainen leads the Predictive Medicine group at Department of Medical Epidemiology and Biostatistics at Karolinska Institute in Sweden.

Maria Pernemalm

Maria Pernemalm, Assistant Professor, Department of Oncology and Pathology at Karolinska Institutet

Asif Jan

Asif Jan joined Owkin from Roche where he was Global Head of Analytics (Personalised Healthcare) in the Pharma Product Development division.

Maj-Britt Juhl Poulsen

Executive Advisor, PhD Danish Regions, Ph.D. in Science and Technology Studies and a Master Degree of Biochemistry.

Merike Leego, MBA, MSc

Merike Leego, MBA, MSc, is Innovation Manager at EIT Health Scandinavia, the European Commission funded network.

Anna Wedell, MD, PhD

Anna Wedell, MD, PhD, Professor at Karolinska Institutet and Senior Consultant at the Centre for Inherited Metabolic Diseases

Mattias Paulsson, PhD

Mattias Paulsson, PhD, Deputy chief pharmacist, Uppsala University Hospital, Sweden

Bettina Lundgren CEO, M.D., D.M.Sc.

CEO of Danish National Genome Center.

Seppo Vainio

Seppo Vainio is a professor of developmental biology at the University of Oulu, Finland.

Per B. Andersen

Per B. Andersen, based in Copenhagen has 15 years of experience with Diagnostic testing pathways and assays.

Nick Baker

Nick has over 20 years experience in regulatory affairs for IVD’s first at the British Standards Institute and then at Lloyd’s Register Quality Assurance (LRQA)

Thorunn Rafnar

Thorunn Rafnar is the Head of Oncology at Reykjavik-based deCODE genetics. She received a Ph.D. degree at the University of North Carolina in 1990

Åslaug Helland

Oncologist, Oslo University Hospital, Head of Research, Oslo Comprehensive Cancer Center, OUS, Professor University of Oslo, Norway

Anagha Joshi

Anagha Joshi is a Professor in Bioinformatics at the faculty of medicine at the University of Bergen since 2018.

Cindy Lawley

Cindy is Global Director of Population Health (Olink), speaker at Nordic PMF 2022.

Tobias Sjöblom

Tobias Sjöblom, Professor in Tumor Genetics at Uppsala University, Sweden.

Richard Rosenquist Brandell

Professor of Clinical Genetics at Karolinska Institutet, and Senior Physician at Karolinska University Hospital.

Stephen A. Williams

Steve Williams is currently responsible for Clinical R&D, Medical Affairs and Regulatory and Quality.

Per Wessman, Ph D

Dr Wessman holds a position as Principal Scientist in product development and formulation.

Per-Johan Jakobsson

Per-Johan Jakobsson, Consultant Rheumatologist and Professor in Translational Inflammation Research

Päivi Östling

Päivi Östling has more than 10 years of research experience in the field of precision cancer medicine (PCM) research.

Prof. Andres Metspalu

Prof. Andres Metspalu, Head of the Estonian Biobank, Institute of Genomics, University of Tartu.

Hege G. Russnes, MD, PhD

Head, Section for experimental pathology and Research Support, Dept. of Pathology, Oslo University Hospital, Norway

Prof. Neeme Tõnisson

Neeme Tõnisson is a Professor of Clinical Genetics and group leader in the Institute of Genomics, Univ. of Tartu / Estonian Biobank

Judith Kairies

Judith Kairies is experienced within regulatory affairs and quality assurance in the life science industry.

Agneta Larhed, PhD

Agneta Larhed, PhD, senior pharmaceutical consultant, OnDosis, Mölndal, Sweden and RegSmart, Uppsala, Sweden

Kjetil Taskén M.D., Ph.D.

Professor of Medicine at University of Oslo in 2001 and since 2018 served as Head of the Institute of Cancer Research, Oslo University Hospital

Prof. Dr. Janne Lehtiö

Since 2015 Janne Lehtiö has held the faculty professor position in Medical Proteomics at Karolinska Institutet, Stockholm, Sweden

Malin Eklund, PhD

Malin Eklund has a PhD in biotechnology from the Royal Institute of Technology, KTH in Stockholm Sweden.

Frida Lundmark

Frida Lundmark joined Lif in 2020 as an expert within Life Science, research and innovation

Dr. Léon van Kempen

Dr. Léon van Kempen is a Clinical Scientist in Molecular Pathology at the department of Pathology, University Medical Center Groningen,

Sebastian Schwarz

Sebastian graduated from HEC Paris and Ecole polytechnique with a double degree in Data Science for Business.

Chris Wigley

Chris Wigley is the CEO of Genomics England, which exists to push insights from cutting edge genomics data analytics into routine medical care.

Kári Stefánsson, M.D.

Kári Stefánsson, M.D., Dr. Med. is founder and CEO of Reykjavik-based deCODE genetics. In Iceland

Carolina Donnerin

Carolina Donnerin is an innovation and project manager at RISE. Her background includes international experience of healthcare transformation and digital innovation.

Zsolt Illes MD

Zsolt Illes MD, PhD is a professor at the University of Southern Denmark (Institute of Clinical Research, BRIDGE and Institute of Molecular Medicine).

Professor Dame Sue Hill

Chief Scientific Officer for England and the Senior Responsible Officer for Genomics in the NHS

Dr Jutta Heix

Head of International Affairs at Oslo Cancer Cluster, is a life science professional with more than 20 years of industry experience.

Dr Cristina Legido-Quigley

Head of Systems Medicine at Steno Diabetes Center Copenhagen and an Associate Professor at King’s College London.

Nils J. Færgeman

Nils J. Færgeman, Professor and Director of the molecular metabolism and metabolomics unit at the University of Southern Denmark

Joni Komulainen

Senior Ministerial Advisor, Ministry of Social Affairs and Health, Finland

Patrik Georgii-Hemming

Patrik Georgii-Hemming is Chief Medical Information Officer at Karolinska University Hospital.

Mohsen Shadidi

Mohsen Shadidi, Head of Section for Molecular Pathology, Department of Pathology, Oslo University Hospital

Grethe S. Foss

Grethe S. Foss is Senior Adviser and Project Leader for personalised medicine at the Norwegian Directorate of Health.

Tuuli Lappalainen, PhD

Tuuli Lappalainen, PhD, Professor at KTH Royal Institute of Technology.

Mathieu Andreux

Mathieu completed his training with a PhD in Deep Learning and Signal Processing at PSL university and ENS Paris.

Prof. Kristian Hveem

Kristian Hveem,Professor in Medicine and Clinical Epidemiology at the Faculty of Medicine and Health Sciences, at the NTNU

Peter Asplund

Peter is Co-founder and Project Director MEGALIT. Director Department of Anestethic and Intensive Care, Region Örebro Län, Örebro, Sweden

Katarina Nyström

Legal counsel at Sahlgrenska University Hospital since 2015. In 2020 she started to work for Genomic Medicine Sweden

Bengt Persson

Professor of bioinformatics at Uppsala University, Director of NBIS (National Bioinformatics Infrastructure Sweden, the SciLifeLab Bioinformatics platform)

Margareta Haag

Margareta Haag, Chair, Swedish Network Against Cancer

Ebba Hallersjö Hult

Ebba Hallersjö Hult, Co-founder and Head of the Innovation Milieus Vision Zero Cancer

Anna Martling

Anna Martling is a Professor of Surgery at Karolinska Institutet, Stockholm, Sweden.

Bettina Lundgren CEO, M.D., D.M.Sc.

CEO of Danish National Genome Center. Danish National Genome Center was established 1st of May 2019.

Annika Ahlford, PhD

Annika has been with Devyser since 2015, first as Technical Lead at R&D department and since June 2021 as Product Manager

Dr Bettina Ryll

Bettina Ryll, MD/PhD works as subject expert for personalised medicine for Vision Zero Cancer

Henrik Eriksson

Is involved in Genome Medicine Sweden projektet i AP2 Infrastruktur & informatic.

Matej Orešič PhD

PhD in Biophysics from Cornell University. Professor of Medicine with Specialization in Systems Medicine at Örebro University

Thorben Seeger

Thorben Seeger is the mastermind behind Lifebit’s international commercial operations.

Leon du Toit

Leon du Toit has over 10 years’ experience in developing IT solutions. Speaker at P{recision Medicine Forum 2022

Sponsorship Opportunities

Nordic Precision Medicine Forum offers a unique environment to make new connections, share ideas and formulate partnerships for future collaboration. We work closely with our sponsors to ensure that your objectives are met by building bespoke marketing solutions. So be it a plenary speaking slot, hosting a roundtable or exhibiting at our forum, we ensure you are in front of the right audience.

Nordic 2022 Speakers

Sponsorship Opportunities

Keep up with everything PMF

Subscribe today

Precision Medicine Forum

Company Pages

Our Conferences